Clinical and Molecular Hepatology

Search

Close

Original Articles The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2014;20(1):47-55.
Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal
Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol. 2014;20(2):185-191.
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2013;19(4):409-416.

Go to Top